{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:07:52Z","timestamp":1786118872422,"version":"build-2736575974"},"reference-count":33,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,6]]},"DOI":"10.1097\/fpc.0000000000000338","type":"journal-article","created":{"date-parts":[[2018,5,15]],"date-time":"2018-05-15T20:18:52Z","timestamp":1526415532000},"page":"139-146","source":"Crossref","is-referenced-by-count":3,"title":["The hemodynamic response to constant dobutamine infusion"],"prefix":"10.1097","volume":"28","author":[{"given":"Dotan","family":"Yogev","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maamoun","family":"Basheer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amichai","family":"Perlman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simcha","family":"Blotnick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoseph","family":"Caraco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mordechai","family":"Muszkat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-1-20210213","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/S0026-895X(25)11439-9","article-title":"A new approach to determine rates of receptor appearance and disappearance in vivo. Application to agonist-mediated down-regulation of rat renal cortical beta-1 and beta-2 adrenergic receptors","volume":"27","author":"Snavely","year":"1985","journal-title":"Mol Pharmacol"},{"key":"R2-1-20210213","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/S0022-3565(25)20374-3","article-title":"In vivo interactions between beta-1 and beta-2 adrenoceptors regulate catecholamine tachyphylaxia in human adipose tissue","volume":"259","author":"Arner","year":"1991","journal-title":"J Pharmacol Exp Ther"},{"key":"R3-1-20210213","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/0002-9343(86)90148-8","article-title":"Importance of receptor regulation in the pathophysiology and therapy of congestive heart failure","volume":"80","author":"Ruffolo","year":"1986","journal-title":"Am J Med"},{"key":"R4-1-20210213","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1007\/s00059-002-2434-z","article-title":"The \u03b2-adrenergic receptors","volume":"27","author":"Wallukat","year":"2002","journal-title":"Herz"},{"key":"R5-1-20210213","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1161\/01.RES.59.3.297","article-title":"Beta-1 and beta-2 adrenergic receptor subpopulations in nonfailing and failing human ventricular myocardium: coupling of both receptor subtypes to muscle contraction and selective beta-1 receptor down regulation in heart failure","volume":"59","author":"Bristow","year":"1986","journal-title":"Circ Res"},{"key":"R6-1-20210213","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1093\/eurjhf\/hfs175","article-title":"Association between adrenergic receptor genotypes and beta-blocker dose in heart failure patients: Analysis from the HF-ACTION DNA substudy","volume":"15","author":"Fiuzat","year":"2013","journal-title":"Eur J Heart Fail"},{"key":"R7-1-20210213","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1067\/mhj.2002.125325","article-title":"Polymorphisms of the\u00a0beta-1 adrenergic receptor predict exercise capacity in heart failure","volume":"144","author":"Wagoner","year":"2002","journal-title":"Am Heart J"},{"key":"R8-1-20210213","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1254\/jphs.CRJ06001X","article-title":"Cardiac adrenoceptors: physiological and pathophysiological relevance","volume":"100","author":"Brodde","year":"2006","journal-title":"J Pharmacol Sci"},{"key":"R12-1-20210213","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/0002-9343(80)90387-3","article-title":"Tolerance to dobutamine after a 72h continuous infusion","volume":"69","author":"Unverferth","year":"1980","journal-title":"Am J Med"},{"key":"R13-1-20210213","doi-asserted-by":"crossref","first-page":"R166","DOI":"10.1152\/ajpregu.2001.280.1.R166","article-title":"A single bout of exercise induces beta-adrenergic desensitization in human adipose tissue","volume":"280","author":"Marion-Latard","year":"2001","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"R14-1-20210213","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1097\/FPC.0000000000000174","article-title":"Effects of sex and the common ADRB1389 genetic polymorphism on the hemodynamic response to dobutamin","volume":"25","author":"Yogev","year":"2015","journal-title":"Pharmacogenet Genomics"},{"key":"R15-1-20210213","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1097\/00008571-200411000-00001","article-title":"The Arg389Gly beta-1 adrenoceptor gene polymorphism determines contractile response to catecholamines","volume":"14","author":"La Rosee","year":"2004","journal-title":"Pharmacogenetics"},{"key":"R16-1-20210213","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1097\/FPC.0b013e32835afde6","article-title":"The common Arg389gly ADRB1 polymorphism affects heart rate response to the ultra-short-acting \u03b21 adrenergic receptor antagonist esmolol in healthy individuals","volume":"23","author":"Muszkat","year":"2013","journal-title":"Pharmacogenet Genomics"},{"key":"R17-1-20210213","doi-asserted-by":"crossref","first-page":"2111","DOI":"10.1016\/j.jacc.2005.08.041","article-title":"The Arg389Gly beta-1 adrenoceptor polymorphism and catecholamine effects on plasma-renin activity","volume":"46","author":"Bruck","year":"2005","journal-title":"J Am Coll Cardiol"},{"key":"R18-1-20210213","doi-asserted-by":"crossref","first-page":"30429","DOI":"10.1074\/jbc.M200681200","article-title":"The myocardium-protective Gly-49 variant of the \u03b21-adrenergic receptor exhibits constitutive activity and increased desensitization and down-regulation","volume":"277","author":"Levin","year":"2002","journal-title":"J Biol Chem"},{"key":"R19-1-20210213","doi-asserted-by":"crossref","first-page":"12670","DOI":"10.1074\/jbc.274.18.12670","article-title":"A gain-of-function polymorphism in a G-protein coupling domain of the human\u00a0beta-1 adrenergic receptor","volume":"274","author":"Mason","year":"1999","journal-title":"J Biol Chem"},{"key":"R20-1-20210213","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1016\/S0002-9149(00)01100-0","article-title":"Safety and efficacy of an accelerated dobutamine stress echocardiography protocol in the evaluation of coronary artery disease","volume":"86","author":"Burger","year":"2000","journal-title":"Am J Cardiol"},{"key":"R21-1-20210213","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1016\/j.amjcard.2012.05.029","article-title":"Response to catecholamine stimulation of polymorphisms of the beta-1 and beta-2 adrenergic receptors","volume":"110","author":"McLean","year":"2012","journal-title":"Am J Cardiol"},{"key":"R22-1-20210213","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1111\/pace.12860","article-title":"Association between beta-1 adrenergic receptor polymorphism and risk of ICD shock in heart failure patients","volume":"39","author":"Zanolla","year":"2016","journal-title":"Pacing Clin Electrophysiol"},{"key":"R23-1-20210213","doi-asserted-by":"crossref","first-page":"121","DOI":"10.2165\/00044011-200828020-00006","article-title":"Pharmacokinetic-pharmacodynamic relationship of dobutamine and heart rate, stroke volume and cardiac output in healthy volunteers","volume":"28","author":"Ahonen","year":"2008","journal-title":"Clin Drug Investig"},{"key":"R24-1-20210213","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1097\/HJH.0b013e328333d212","article-title":"Desensitization of vascular response in vivo: contribution of genetic variation in the [alpha]2B-adrenergic receptor subtype","volume":"28","author":"Muszkat","year":"2010","journal-title":"J Hypertens"},{"key":"R25-1-20210213","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1007\/s10741-007-9014-5","article-title":"Classical inotropes and new cardiac enhancers","volume":"12","author":"Parissis","year":"2007","journal-title":"Heart Fail Rev"},{"key":"R26-1-20210213","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1136\/hrt.75.5.463","article-title":"Cardiovascular effects of dobutamine stress testing in women with suspected coronary artery disease","volume":"75","author":"Blomstrand","year":"1996","journal-title":"Heart"},{"key":"R27-1-20210213","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1111\/j.1540-8175.2007.00487.x","article-title":"Gender differences in chronotropic and hemodynamic responses during dobutamine-atropine stress echocardiography","volume":"24","author":"Tsutsui","year":"2007","journal-title":"Echocardiography"},{"key":"R28-1-20210213","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1016\/S0002-9149(97)00707-8","article-title":"Gender differences in the accuracy of dobutamine stress echocardiography for the diagnosis of coronary artery disease","volume":"80","author":"Elhendy","year":"1997","journal-title":"Am J Cardiol"},{"key":"R29-1-20210213","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.amjcard.2004.04.076","article-title":"Influence of gender and race on hemodynamic response to dobutamine during dobutamine stress echocardiography","volume":"94","author":"Aquilante","year":"2004","journal-title":"Am J Cardiol"},{"key":"R30-1-20210213","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1016\/j.amjcard.2003.08.058","article-title":"Variability of inotropic and chronotropic response during dobutamine stress echocardiography and possible implications for diagnostic accuracy","volume":"92","author":"Chenzbraun","year":"2003","journal-title":"Am J Cardiol"},{"key":"R31-1-20210213","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1093\/ehjci\/jev165","article-title":"Typical blood pressure response during dobutamine stress echocardiography of patients without known cardiovascular disease who have normal stress echocardiograms","volume":"17","author":"Abram","year":"2016","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"R32-1-20210213","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1093\/ejechocard\/jen175","article-title":"Stress echocardiography expert consensus statement","volume":"9","author":"Sicari","year":"2008","journal-title":"Eur J Echocardiogr"},{"key":"R33-1-20210213","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1016\/j.echo.2007.07.003","article-title":"American Society of Echocardiography recommendations for performance, interpretation, and application of stress echocardiography","volume":"20","author":"Pellikka","year":"2007","journal-title":"J Am Soc Echocardiogr"},{"key":"R34-1-20210213","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1161\/01.CIR.86.2.504","article-title":"Differences in cardiovascular responses to isoproterenol in relation to age and exercise training in healthy men","volume":"86","author":"Stratton","year":"1992","journal-title":"Circulation"},{"key":"R35-1-20210213","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1111\/j.1365-2125.2006.02657.x","article-title":"Dose-dependent effect of dobutamine on chemoreflex activity in healthy volunteers","volume":"62","author":"Pathak","year":"2006","journal-title":"Br J Clin Pharmacol"},{"key":"R36-1-20210213","first-page":"1","article-title":"Adiposity is associated with gender-specific reductions in left ventricular myocardial perfusion during dobutamine stress","volume":"11","author":"Hall","year":"2016","journal-title":"PLoS One"}],"container-title":["Pharmacogenetics and Genomics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/FPC.0000000000000338","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T17:12:32Z","timestamp":1786036352000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/01213011-201806000-00001"}},"subtitle":["the effect of ADRB1 389 polymorphism and sex"],"short-title":[],"issued":{"date-parts":[[2018,6]]},"references-count":33,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2018]]}},"URL":"https:\/\/doi.org\/10.1097\/fpc.0000000000000338","relation":{},"ISSN":["1744-6872"],"issn-type":[{"value":"1744-6872","type":"print"}],"subject":[],"published":{"date-parts":[[2018,6]]}}}